United States · FDA National Drug Code directory
diflunisal
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 14539-673_7616a7e4-96d0-4581-9b77-e9292726282b
- Product NDC
- 14539-673
- Form
- TABLET, FILM COATED
- Composition / generic term
- diflunisal
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120308
- Source listing expiry
- 20271231
Source-listed ingredients
- DIFLUNISAL — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (14539-673-01) · 14539-673-01
- 500 TABLET, FILM COATED in 1 BOTTLE (14539-673-05) · 14539-673-05
- 60 TABLET, FILM COATED in 1 BOTTLE (14539-673-06) · 14539-673-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →